Biochemistry · Topic
Insulin signalling !
Insulin is the fed-state hormone: it makes muscle and fat take up glucose and makes the liver store instead of release.
Updated 2026-11-01
Key facts
- The beta cell cuts proinsulin into insulin and C-peptide in equal amounts; C-peptide tells the body's own insulin from injected insulin.
- Secretion: glucose enters the beta cell, glucokinase phosphorylates it, ATP rises, the K-ATP channel closes, the membrane depolarises and Ca²⁺ entry releases the granules.
- The receptor is a tyrosine kinase: it activates IRS → PI3K → Akt (metabolic effects) and Ras → MAPK (growth).
- Akt moves GLUT4 to the membrane of muscle and fat; liver and brain do not depend on GLUT4.
- Insulin also drives potassium into cells (Na⁺/K⁺ pump): that is why it can cause hypokalaemia.
In detail
- Insulin binds the receptor's α subunit; the β subunits phosphorylate each other on tyrosines and recruit the insulin receptor substrates (IRS-1, IRS-2).
- IRS activates PI3K, which makes PIP3 in the membrane; PDK1 and mTORC2 activate Akt (protein kinase B).
- Akt inhibits GSK3 (glycogen synthase stays active), activates PDE3B (cAMP falls and PKA switches off) and moves FoxO1 out of the nucleus (less PEPCK and glucose 6-phosphatase).
- In the liver insulin activates a phosphatase that dephosphorylates PFK-2: fructose 2,6-bisphosphate rises and glycolysis speeds up. It also activates acetyl-CoA carboxylase and SREBP-1c (lipogenesis).
- In adipose tissue it slows hormone-sensitive lipase (by lowering cAMP) and raises lipoprotein lipase: fat is stored.
- The signal is switched off by phosphatases (PTP1B, PTEN) and by serine phosphorylation of IRS-1 (JNK, IKKβ, S6K1, PKC), a central mechanism of insulin resistance.
Clinical notes
- Type 1 diabetes: insulin is missing (autoimmunity against the beta cell). Type 2 diabetes: insulin resistance plus progressive beta-cell failure.
- Sulfonylureas close the K-ATP channel and release insulin; diazoxide opens it and holds insulin back (used in insulinoma).
- High insulin with low C-peptide suggests exogenous insulin; both high suggest an insulinoma or sulfonylureas.
- Acanthosis nigricans (dark, velvety skin on the neck and armpits) is a sign of hyperinsulinaemia.
Pathways
Related conditions
Related
- Insulin receptor
- Receptor tyrosine kinases
- mTOR (mechanistic target of rapamycin)
- Glucagon signalling
- Fed, fasting and starvation states
- Glycogen synthase
- Acetyl-CoA carboxylase (ACC)
- Hormone-sensitive lipase (HSL)
- Lipoprotein lipase (LPL)
- Glucose
- Cyclic AMP (cAMP)
Test yourself
Think of the answer, then tap the question to see it.
What closes the beta cell's K-ATP channel after a meal?
The rise in ATP from glucose metabolism; closure depolarises the cell and Ca²⁺ entry releases insulin.
Which insulin receptor pathway moves GLUT4 to the membrane?
The IRS → PI3K → Akt pathway; the Ras–MAPK pathway mainly handles growth.
How does insulin stop lipolysis?
It activates phosphodiesterase 3B, cAMP falls and PKA stops activating hormone-sensitive lipase.
Which test tells the body's own insulin from injected insulin?
C-peptide: it is secreted with endogenous insulin and is absent from pharmaceutical insulins.
Why can insulin lower blood potassium?
Because it stimulates the Na⁺/K⁺-ATPase and potassium moves into cells.
Educational information, not medical advice. For any symptom, see a health professional.
Sources: INS: Insulin (human) (UniProt, 2026); INSR: Insulin receptor (human) (UniProt, 2026); INSR gene: MedlinePlus Genetics (MedlinePlus, US National Library of Medicine, 2026); Insulin C-peptide test: MedlinePlus Medical Encyclopedia (MedlinePlus, US National Library of Medicine, 2026); Textbook of Biochemistry for Medical Students, 6th ed. (Jaypee Brothers Medical Publishers (Vasudevan DM, Sreekumari S, Vaidyanathan K), 2011).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.